GEA
AVNS

Glen Eagle Advisors’s Avanos Medical AVNS Stock Holding History

Glen Eagle Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17
Closed -$208 – 1123
2025
Q2 		$208 Hold
17
– – ﹤0.01% 1015
2025
Q1 		$244 Hold
17
– – ﹤0.01% 1029
2024
Q4 		$271 Hold
17
– – ﹤0.01% 1053
2024
Q3 		$409 Hold
17
– – ﹤0.01% 1079
2024
Q2 		$339 Hold
17
– – ﹤0.01% 1083
2024
Q1 		$338 Hold
17
– – ﹤0.01% 1045
2023
Q4 		$381 Hold
17
– – ﹤0.01% 980
2023
Q3 		$344 Hold
17
– – ﹤0.01% 983
2023
Q2 		$435 Sell
17
-3
-15% -$79 ﹤0.01% 1010
2023
Q1 		$595 Buy
20
+3
+18% +$87 ﹤0.01% 993
2022
Q4 		$460 Hold
17
– – ﹤0.01% 1089
2022
Q3 		$370 Hold
17
– – ﹤0.01% 1037
2022
Q2 		$465 Hold
17
– – ﹤0.01% 946
2022
Q1 		$570 Hold
17
– – ﹤0.01% 899
2021
Q4 		$589 Hold
17
– – ﹤0.01% 883
2021
Q3 		$530 Hold
17
– – ﹤0.01% 1013
2021
Q2 		$618 Hold
17
– – ﹤0.01% 991
2021
Q1 		$744 Hold
17
– – ﹤0.01% 953
2020
Q4 		$780 Hold
17
– – ﹤0.01% 921
2020
Q3 		$565 Buy
+17
New +$543 ﹤0.01% 876

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Glen Eagle Advisors's AVNS Position: Q3 2025 in Review

Glen Eagle Advisors sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 17 shares — an estimated $208 sold.

Glen Eagle Advisors first reported a position in AVNS in Q3 2020 and held it in 20 quarters. The position peaked at $780 in Q4 2020. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Glen Eagle Advisors reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Glen Eagle Advisors sold 17 Avanos Medical shares in Q3 2025, an estimated $208.
  • Glen Eagle Advisors first reported a position in Avanos Medical in Q3 2020 and held it in 20 quarters.
  • Glen Eagle Advisors's Avanos Medical position peaked at $780 in Q4 2020.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Glen Eagle Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.